Fortis Healthcare Brings Bhavdeep Singh back as CEO

Published On 2015-07-25 05:28 GMT   |   Update On 2015-07-25 05:28 GMT

After a successful innings as the CEO from 2009 to 2011, Bhavdeep Singh has been reappointed by the management citing his continuity and immense knowledge of the healthcare spaceFortis Healthcare has announced the reappointment of Bhavdeep Singh as the CEO of the company. Bhuvdeep’s appointment comes after his previous innings as the CEO of Fortis between 2009 and 2011. The management...

Login or Register to read the full article

After a successful innings as the CEO from 2009 to 2011, Bhavdeep Singh has been reappointed by the management citing his continuity and immense knowledge of the healthcare space


Fortis Healthcare has announced the reappointment of Bhavdeep Singh as the CEO of the company. Bhuvdeep’s appointment comes after his previous innings as the CEO of Fortis between 2009 and 2011. The management has clearly cited the continuity factor, and Bhavdeep's deep understanding of the healthcare space as main reasons for his reappointment at the helm of the company’s affairs.


As reported by PTI,


In November last year, after Aditya Vij stepped down as the company's CEO, Executive Vice Chairman Shivinder Mohan Singh had assumed additional responsibility for the company's operations while the search for a new CEO was on.


The Singh brothers further said, he is on familiar ground and has a deep understanding of the healthcare space, first-hand knowledge of Fortis, it's culture and strategy.


Prior to this appointment, Bhavdeep was most recently with Ahold, an $26 billion Dutch retailer with almost 800 stores.


"His deep experience in India and overseas in the retail and services sector will be particularly valuable as we relentlessly pursue our vision to create a world-class integrated healthcare delivery system, with a focus on India," they said.


On his appointment, Bhavdeep said: "I am excited to be back in India and very excited to be back at Fortis. The Indian healthcare market is poised for rapid growth and Fortis, at an inflexion point, is strategically placed on its growth trajectory."

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News